| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACTN4
|
actinin, alpha 4
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADD3
|
adducin 3 (gamma)
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ANXA2
|
annexin A2
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
|
ARHGAP5
|
Rho GTPase activating protein 5
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
CA9
|
carbonic anhydrase IX
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCND1
|
cyclin D1
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25C
|
cell division cycle 25C
|
|
CDCA5
|
cell division cycle associated 5
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLDN7
|
claudin 7
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CROCC
|
ciliary rootlet coiled-coil, rootletin
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CTTN
|
cortactin
|
|
CUX1
|
cut-like homeobox 1
|
|
DAXX
|
death-domain associated protein
|
|
DCD
|
dermcidin
|
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5
|
|
DNM2
|
dynamin 2
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
ENO1
|
enolase 1, (alpha)
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB1
|
EPH receptor B1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
EZR
|
ezrin
|
|
FAM84A
|
family with sequence similarity 84, member A
|
|
FBXO4
|
F-box protein 4
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FHIT
|
fragile histidine triad
|
|
FLCN
|
folliculin
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA2
|
forkhead box A2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H2AFX
|
H2A histone family, member X
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HCN2
|
hyperpolarization activated cyclic nucleotide gated potassium channel 2
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IP6K2
|
inositol hexakisphosphate kinase 2
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB4
|
integrin, beta 4
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KDR
|
kinase insert domain receptor
|
|
KRT18
|
keratin 18, type I
|
|
KRT8
|
keratin 8, type II
|
|
KSR1
|
kinase suppressor of ras 1
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LTA4H
|
leukotriene A4 hydrolase
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MARCKSL1
|
MARCKS-like 1
|
|
MBP
|
myelin basic protein
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MVP
|
major vault protein
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
NANOG
|
Nanog homeobox
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NEUROG1
|
neurogenin 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPY1R
|
neuropeptide Y receptor Y1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PHGDH
|
phosphoglycerate dehydrogenase
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRLR
|
prolactin receptor
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK6
|
protein tyrosine kinase 6
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PXN
|
paxillin
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RALBP1
|
ralA binding protein 1
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SDC4
|
syndecan 4
|
|
SEC14L2
|
SEC14-like 2 (S. cerevisiae)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIRT1
|
sirtuin 1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD5
|
SMAD family member 5
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNAI1
|
snail family zinc finger 1
|
|
SP1
|
Sp1 transcription factor
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STARD10
|
StAR-related lipid transfer (START) domain containing 10
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STMN1
|
stathmin 1
|
|
SUGT1
|
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
|
|
SYK
|
spleen tyrosine kinase
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAGLN2
|
transgelin 2
|
|
TCP1
|
t-complex 1
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TFRC
|
transferrin receptor
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TLR4
|
toll-like receptor 4
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
URI1
|
URI1, prefoldin-like chaperone
|
|
USP10
|
ubiquitin specific peptidase 10
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
